Celltrion Healthcare is a global biopharmaceutical company committed to delivering affordable quality therapeutics for patients. Access to advanced yet costly therapeutics is often a challenge to patients and healthcare providers. In particular, biologics have become an increasingly important but also expensive part of the global medicine cabinet. We believe that every patient deserves access to treatments they need. Based on this belief, Celltrion Healthcare has been steadfast in our mission to meet the needs of patients who previously had limited access to advanced therapeutics since our inception in 1999 by developing biosimilar products. As a result, our biosimilar products approved in over 90 countries and already prescribed in majority of these approved countries. Ushering a new era of biologics in, we strive to offer high quality and cost-effective solutions in breakthrough therapies and contribute to improving global healthcare.
Celltrion specializes in the research and development of high quality mAbs and innovative biopharmaceuticals utilizing its accumulated R&D technology and production capabilities. Celltrion boasts one of the world’s largest state-of-the-art mammalian cell culture plants with a total production capacity of 140,000L. Celltrion Healthcare conducts worldwide marketing, sales and distribution of biological medicines developed by Celltrion through an extensive global network, including both developed and emerging markets